To explore the role of SNAP25 in chemoresistance, we treated SNAP25 knockdown and SNAP25-overexpressing GNEC cell lines with chemotherapeutic agents commonly used in gastric cancer. This evidence concerns the gene SNAP25 and gastric cancer.